Inicio>>Signaling Pathways>> Others>>Polaprezinc (Zinc L-carnosine)

Polaprezinc (Zinc L-carnosine)

Catalog No.GC31723

Polaprezinc (Zinc L-carnosina) es un quelato biodisponible por vÍa oral compuesto de zinc y L-carnosina, con potencial gastroprotector, antioxidante, antiulceroso y antiinflamatorio.

Products are for research use only. Not for human use. We do not sell to patients.

Polaprezinc (Zinc L-carnosine) Chemical Structure

Cas No.: 107667-60-7

Tamaño Precio Disponibilidad Cantidad
10mg
46,00 $
Disponible
50mg
110,00 $
Disponible
100mg
175,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Polaprezinc is an orally bioavailable chelate composed of zinc and L-carnosine, with potential gastroprotective, anti-oxidant, anti-ulcer and anti-inflammatory activities.

Polaprezinc (PZ) is an antiulcer drug and a chelating compound consisting of a zinc ion, L-carnosine, a β-alanine dipeptide and L-histidine. Polaprezinc exerts antioxidant effects and scavenges free radicals. The efficacy of Polaprezinc is reported for acute radiation proctitis in an animal model and demonstrates that Polaprezinc has an anti-inflammatory effect following exposure to radiation[1].

[1]. Odawara S, et al. Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice. Mol Clin Oncol. 2016 Oct;5(4):377-381.

Reseñas

Review for Polaprezinc (Zinc L-carnosine)

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Polaprezinc (Zinc L-carnosine)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.